Inter-observer agreement of tumor infiltrating lymphocytes in primary HER2-positive breast cancer and correlation between tissue microarray and full tumor-sections

Frances Mary Reznitsky*, Jeanette Dupont Jensen, Ann Knoop, Anne Vibeke Laenkholm

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

2 Citations (Scopus)
11 Downloads (Pure)

Abstract

Tumor infiltrating lymphocytes (TILs) have predictive and prognostic potential in HER2-positive breast cancer (HER2 + BC). Due to tumor heterogeneity, guidelines recommend evaluation on full tumor-sections over biopsies, but aren't clear regarding tissue microarrays (TMAs). Herein, we investigate the inter-observer agreement of TILs assessment in HER2 + BC on full-sections and TMAs using a standardized method. Two pathologists assessed TILs using HE full-sections and TMAs from 244 patients with HER2 + BC. TILs were assessed in 10% intervals; values <10% evaluated as 0%, 1% or 5%. Levels of agreement were evaluated using intraclass-coefficient (ICC), Kappa statistics and concordance analysis. For inter-observer agreement for full-sections, ICC was 0.93 (95% CI 0.89–0.95) and Kappa was 0.75, corresponding to acceptable and moderate agreement respectively. For TMAs, ICC was 0.73 (95% CI: 0.62–0.81) and Kappa 0.33, corresponding to unacceptable agreement. For association in matched TMA and full-sections, ICC was 0.64 (95% CI 0.55–0.71) and Lin's concordance correlation coefficient was 0.63 (95% CI 0.55–0.71), corresponding to unacceptable agreement. There is acceptable inter-observer agreement of TILs assessment on full-sections but not TMAs and discrepancy between full-sections and TMAs. TMA preparation must include consideration for representation of both entire tumor area and tumor-microenvironment to correctly define prognostic and predictive values of potential immuno-related biomarkers.

Original languageEnglish
JournalAPMIS
Volume130
Issue number9
Pages (from-to)545-550
ISSN0903-4641
DOIs
Publication statusPublished - 2022

Bibliographical note

Funding Information:
The authors would like to thank the laboratory at the Pathology department, Zealand University Hospital for their work with TMA production. This study was funded by the Department of Pathology, Zealand University Hospital.

Keywords

  • full-sections
  • HER2-positive breast cancer
  • inter-observer agreement
  • TMA
  • tumor infiltrating lymphocytes

Cite this